Small Trial Results: Hydroxychloroquine Effective For COVID-19 Treatment

Small Trial Results: Hydroxychloroquine Effective For COVID-19 Treatment


1
404
https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-320x140.jpg 320w, https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-640x2... 640w, https://www.veteranstoday.com/wp-content/uploads/COVID-19_001-768x3... 768w" sizes="(max-width: 1000px) 100vw, 1000px" alt="" title="COVID-19_001" />

HCQ Effective for COVID-19 in Small Randomized Trial

by Molly Walker, Associate Editor, MedPage Today

Hospitalized patients in China with COVID-19 coronavirus treated with hydroxychloroquine (HCQ), an antimalarial also used to treat autoimmune diseases, had a shorter time to clinical recovery, as well as improved pneumonia, a randomized trial found.

Patients randomized to receive hydroxychloroquine with standard treatment had a significantly shorter time to body temperature recovery of about a day, as well as a significantly reduced time to cough remission of about a day versus patients receiving only standard treatment, reported Zhan Zhang, MD, of Wuhan University in China, and colleagues.

Moreover, a larger proportion of patients in the HCQ group had improved pneumonia compared with patients in the control group (80.6% vs 54.8%), they wrote in a manuscript posted on the medRxiv preprint server.

HCQ and chloroquine for COVID-19 treatment have been in the spotlight ever since President Trump first touted their benefits in a press briefing 2 weeks ago. The FDA said it was looking into conducting randomized trials of the drug in COVID-19 patients, though some hospitals have already opted for off-label use of these agents.

One person in Arizona died after ingesting chloroquine phosphate, also sold for cleaning fish tanks, prompting the CDC to issue a warning against this practice.

Previous trials had explored in vivo activity of the drug, and one pilot study found no benefit in clinical measures or viral clearance compared with standard of care.

Still, the drug continues to be tested in ad hoc trials, including this one by Zhang and colleagues. They randomized 62 patients hospitalized with laboratory-confirmed COVID-19 infection in February. All patients received standard treatment, including oxygen therapy, antiviral agents, antibacterial agents, and immunoglobulin, with or without corticosteroids; patients in the intervention group also received oral HCQ sulfate tablets 400 mg/day on days 1-5.

Primary endpoint was time to clinical recovery, defined as “return to body temperature and cough relief, maintained for more than 72 [hours].” Mean patient age was about 45 and almost half were men, with no significant differences in the age and sex distribution between groups, the authors said.

Patients in the HCQ group had a significantly shorter time to body temperature recovery versus controls (2.2 days vs 3.2 days, P=0.0008). Similar results were seen for time to cough remission for the HCQ and control groups (2.0 vs 3.1 days, P=0.0016).

They noted four of 62 patients progressed to severe illness, all in the control group.

Two patients reported mild adverse reactions in the HCQ group, one with a rash and one with a headache.

Retinopathy is a known side effect of long-term therapy with HCQ — often seen in lupus patients who may stay on the drug for years — and patients occasionally experience arrhythmias and, more rarely, gastrointestinal reactions, cramps, and liver dysfunction. Patients should be monitored for these, but “short-term application of HCQ is relatively safe,” Zhang and colleagues wrote.

While acknowledging a need for large-scale clinical trials and other research to clarify the specific treatment mechanism and optimize the treatment plan, the authors concluded that “considering that there is no better option at present, it is a promising practice to apply HCQ to COVID-19 under reasonable management.”

Disclosures

This study was supported by the Epidemiological Study of COVID-19 Pneumonia to Science and Technology, Department of Hubei Province.

Zhang and co-authors disclosed no relevant relationships with industry.

Views: 30

Comment

You need to be a member of 12160 Social Network to add comments!

Join 12160 Social Network

Comment by stormtruther on April 2, 2020 at 6:59am

Scientists, however, warn about raising false hopes and say major studies are needed to prove the drugs are safe and effective against coronavirus

https://au.news.yahoo.com/the-controversial-drug-approved-to-fight-...

lamestream are against it ...everything they say is bullshit....therefore it probably works, deductive reasoning Dr Watson

Comment by stormtruther on April 2, 2020 at 6:52am

#9 Wormwood

Artemisinins are derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria, including highly drug-resistant strains.

Artemisinins reduce replication rates of a host of different viruses. Artesunate is effective at stopping viral replication in 100mg per day oral doses (R).

https://men-elite.com/2020/03/13/coronavirus-the-truth-about-the-vi...

Drink Absinth and be merry, I just happen to have one in the yard because i like the buzz....two for the price of one

"Destroying the New World Order"

TOP CONTENT THIS WEEK

THANK YOU FOR SUPPORTING THE SITE!

mobile page

12160.info/m

12160 Administrators

 

Latest Activity

rlionhearted_3 commented on tjdavis's video
Thumbnail

They Don’t Want You to Know How the Committee of 300 Works

"Check this out? A real history lesson. A paragraph from page 105."
3 hours ago
rlionhearted_3 commented on tjdavis's video
3 hours ago
Doc Vega's 8 blog posts were featured
9 hours ago
tjdavis's blog post was featured
9 hours ago
Less Prone favorited Doc Vega's blog post What is The One Common Denominator That Shortens Your Life?
9 hours ago
Less Prone commented on Doc Vega's blog post Don’t you Just Enjoy having Your Intelligence Insulted?
"Yes. It's a ridiculous world run by some greedy perverts who like to play god."
9 hours ago
tjdavis favorited Sandy's video
yesterday
tjdavis posted a video

They Don’t Want You to Know How the Committee of 300 Works

If you found this lecture interesting, continue here: https://theinvisiblepyramid.com/In 1994, researcher and author John Coleman made a serious claim about ...
yesterday
Doc Vega posted a blog post
Saturday
Doc Vega commented on Doc Vega's photo
Thumbnail

HQDAWOjbAAARkld

"Tori Kovach, six fee under? You should try it out first and see how well it fits people like you…"
Saturday
Doc Vega commented on Doc Vega's photo
Thumbnail

HQDAWOjbAAARkld

"Tori Kovach, it's people like you who don't know what the hell you're talking about…"
Saturday
Snakedaddy commented on cheeki kea's photo
Thumbnail

Not sightseeing.

"Did he leave pajeet shit on their beach also?"
Friday
Doc Vega posted blog posts
Wednesday
Doc Vega commented on Doc Vega's photo
Thumbnail

HPiZF7gXIAAC-yn

"The traitors are the Democrat and you got it wrong! They make deals with nations that hate America…"
Wednesday
Doc Vega commented on Doc Vega's photo
Thumbnail

746528467_1383587106979426_270659517669097126_n

"Outsourced American labor was the cause and Trump was lying plants here in the states from major…"
Wednesday
cheeki kea commented on cheeki kea's photo
Thumbnail

Not sightseeing.

"That's a funny one Tori because the natives are not to keen on law enforcement at the best of…"
Wednesday
Tori Kovach commented on Doc Vega's photo
Thumbnail

746528467_1383587106979426_270659517669097126_n

"We wouldn't want for anything if our fucking corporations hadn't sold our jobs to China…"
Tuesday
Tori Kovach commented on Doc Vega's photo
Thumbnail

HPiZF7gXIAAC-yn

"Well, instead we got it backwards and voted for a traitor and got...a traitor."
Tuesday
Tori Kovach commented on cheeki kea's photo
Thumbnail

Not sightseeing.

"I heard the aborigines wanted to keep him as one of their own."
Tuesday
Tori Kovach commented on tjdavis's photo
Thumbnail

Sainthood

"That's why Trump loves you"
Tuesday

© 2026   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2019 - all rights reserved. unless otherwise noted